These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37840489)

  • 1. Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer's Disease Combined with Cerebral Hypoperfusion.
    Bian Z; Hu X; Liu X; Yu H; Bian Y; Sun H; Fukui Y; Morihara R; Ishiura H; Yamashita T
    J Alzheimers Dis; 2023; 96(2):609-622. PubMed ID: 37840489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Effect of Rivaroxaban Against Amyloid Pathology and Neuroinflammation Through Inhibiting PAR-1 and PAR-2 in Alzheimer's Disease Mice.
    Bian Z; Liu X; Feng T; Yu H; Hu X; Hu X; Bian Y; Sun H; Tadokoro K; Takemoto M; Yunoki T; Nakano Y; Fukui Y; Morihara R; Abe K; Yamashita T
    J Alzheimers Dis; 2022; 86(1):111-123. PubMed ID: 35001892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of edaravone on white matter pathology in a novel mouse model of Alzheimer's disease with chronic cerebral hypoperfusion.
    Feng T; Yamashita T; Sasaki R; Tadokoro K; Matsumoto N; Hishikawa N; Abe K
    J Cereb Blood Flow Metab; 2021 Jun; 41(6):1437-1448. PubMed ID: 33106078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and Pathological Benefits of Edaravone for Alzheimer's Disease with Chronic Cerebral Hypoperfusion in a Novel Mouse Model.
    Feng T; Yamashita T; Shang J; Shi X; Nakano Y; Morihara R; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Matsumoto N; Hishikawa N; Ohta Y; Abe K
    J Alzheimers Dis; 2019; 71(1):327-339. PubMed ID: 31403949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical exercise modulates the astrocytes polarization, promotes myelin debris clearance and remyelination in chronic cerebral hypoperfusion rats.
    Jiang T; Luo J; Pan X; Zheng H; Yang H; Zhang L; Hu X
    Life Sci; 2021 Aug; 278():119526. PubMed ID: 33894268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Pathological Benefits of Scallop-Derived Plasmalogen in a Novel Mouse Model of Alzheimer's Disease with Chronic Cerebral Hypoperfusion.
    Feng T; Hu X; Fukui Y; Bian Z; Bian Y; Sun H; Takemoto M; Yunoki T; Nakano Y; Morihara R; Abe K; Yamashita T
    J Alzheimers Dis; 2022; 86(4):1973-1982. PubMed ID: 35253748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roflumilast promotes memory recovery and attenuates white matter injury in aged rats subjected to chronic cerebral hypoperfusion.
    Santiago A; Soares LM; Schepers M; Milani H; Vanmierlo T; Prickaerts J; Weffort de Oliveira RM
    Neuropharmacology; 2018 Aug; 138():360-370. PubMed ID: 29933009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated accumulation of fibrinogen peptide chains with Aβ deposition in Alzheimer's disease (AD) mice and human AD brains.
    Bian Z; Yamashita T; Shi X; Feng T; Yu H; Hu X; Hu X; Bian Y; Sun H; Tadokoro K; Takemoto M; Omote Y; Morihara R; Abe K
    Brain Res; 2021 Sep; 1767():147569. PubMed ID: 34197775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease.
    Miners JS; Schulz I; Love S
    J Cereb Blood Flow Metab; 2018 Jan; 38(1):103-115. PubMed ID: 28151041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model.
    Zhai Y; Yamashita T; Nakano Y; Sun Z; Shang J; Feng T; Morihara R; Fukui Y; Ohta Y; Hishikawa N; Abe K
    J Alzheimers Dis; 2016 Jun; 53(3):893-905. PubMed ID: 27314529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter damage as a consequence of vascular dysfunction in a spontaneous mouse model of chronic mild chronic hypoperfusion with eNOS deficiency.
    Chen X; Chen L; Lin G; Wang Z; Kodali MC; Li M; Chen H; Lebovitz SG; Ortyl TC; Li L; Ismael S; Singh P; Malik KU; Ishrat T; Zhou FM; Zheng W; Liao FF
    Mol Psychiatry; 2022 Nov; 27(11):4754-4769. PubMed ID: 35948662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic cerebral hypoperfusion induces memory deficits and facilitates Aβ generation in C57BL/6J mice.
    Wang L; Du Y; Wang K; Xu G; Luo S; He G
    Exp Neurol; 2016 Sep; 283(Pt A):353-64. PubMed ID: 27421879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalin facilitates remyelination and suppresses neuroinflammation in rats with chronic cerebral hypoperfusion by activating Wnt/β-catenin and inhibiting NF-κB signaling.
    Xiao Y; Guan T; Yang X; Xu J; Zhang J; Qi Q; Teng Z; Dong Y; Gao Y; Li M; Meng N; Lv P
    Behav Brain Res; 2023 Mar; 442():114301. PubMed ID: 36707260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease.
    McAleese KE; Walker L; Graham S; Moya ELJ; Johnson M; Erskine D; Colloby SJ; Dey M; Martin-Ruiz C; Taylor JP; Thomas AJ; McKeith IG; De Carli C; Attems J
    Acta Neuropathol; 2017 Sep; 134(3):459-473. PubMed ID: 28638989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion.
    Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1993-2002. PubMed ID: 31029568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.
    Chung YC; Kruyer A; Yao Y; Feierman E; Richards A; Strickland S; Norris EH
    J Thromb Haemost; 2016 Jul; 14(7):1442-52. PubMed ID: 27090576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia.
    Tayler H; Miners JS; Güzel Ö; MacLachlan R; Love S
    Brain Pathol; 2021 Jul; 31(4):e12935. PubMed ID: 33410232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of White Matter Integrity by Chronic Cerebral Hypoperfusion in Alzheimer's Disease Mouse Model.
    Zhai Y; Yamashita T; Nakano Y; Sun Z; Morihara R; Fukui Y; Ohta Y; Hishikawa N; Abe K
    J Alzheimers Dis; 2016 Apr; 52(4):1311-9. PubMed ID: 27079724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ameliorative effects of exercise on cognitive impairment and white matter injury from blood-brain barrier disruption induced by chronic cerebral hypoperfusion in adolescent rats.
    Lee JM; Park JM; Song MK; Oh YJ; Kim CJ; Kim YJ
    Neurosci Lett; 2017 Jan; 638():83-89. PubMed ID: 27956237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.